Study Stopped
The recruitment of potential participants is suspended due to the covid-19 pandemic.
Strengthening Program for Foot-ankle Muscles in People With Knee Osteoarthritis
Effects of a Strengthening Program for Foot-ankle Muscles in Clinical Aspects and Gait Biomechanics of People With Knee Osteoarthritis: a Randomized Blinded Clinical Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
The main objective of this trial is To evaluate the effect of an ankle and foot muscle strengthening program on pain, analgesic consumption, functionality, and lower limb biomechanics during gait in individuals with knee osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable knee-osteoarthritis
Started Jan 2020
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2019
CompletedFirst Posted
Study publicly available on registry
November 6, 2019
CompletedStudy Start
First participant enrolled
January 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 4, 2023
CompletedApril 2, 2025
March 1, 2025
1 month
October 31, 2019
March 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline The WOMAC (Western Ontario and McMaster Universities) Pain Subscale at 8 and 16 weeks.
The WOMAC pain subscale consists of five questions (Likert Scale) relating to the patient's pain in everyday situations. The Likert Scale version used for all WOMAC items are: none, mild, moderate, severe, and extreme. The sum of all items of pain subscale ranges from 0 to 20. Higher scores indicate worse pain.
Baseline, 8 weeks and 16 weeks.
Secondary Outcomes (11)
Change from baseline WOMAC (Western Ontario and McMaster Universities) Stiffness Subscale at 8 and 16 weeks.
Baseline, 8 weeks and 16 weeks.
Change from baseline WOMAC (Western Ontario and McMaster Universities) Physical Function Subscale at 8 and 16 weeks.
Baseline, 8 weeks and 16 weeks.
Change from baseline WOMAC (Western Ontario and McMaster Universities) Total Score at 8 and 16 weeks
Baseline, 8 weeks and 16 weeks.
30-second Chair Stand Test
Baseline, 8 weeks and 16 weeks.
9-step Stair Climb Test
Baseline, 8 weeks and 16 weeks.
- +6 more secondary outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALPatients will receive a physical therapy intervention three times per week, for 8 weeks.
Control Group
NO INTERVENTIONPatients will not receive any exercise treatment but they will keep their recommended clinical treatment.
Interventions
Patients will receive a physical therapy intervention for strengthening, stretching and functional training of ankle and foot.
Eligibility Criteria
You may qualify if:
- Knee osteoarthritis (KOA) based on clinical and radiological criteria of American College of Reumathology;
- KOA (Grade II and III - Radiological classification of Kellgreen and Laurence) in medial compartment of knee;
- Knee pain between 30 and 80 on the visual analogue scale;
- BMI \< 35 kg/m2.
You may not qualify if:
- KOA isolated (Grade II and III - Radiological classification of Kellgreen and Laurence) in lateral compartment of knee;
- Lower limb strength training (3 times per week);
- Wear minimalist shoes for at least 6 hours a day and 5 days a week;
- Physical therapy in the previous 3 months;
- Having received steroid injections and hyaluronic acid intra-articular knee in previous periods of three and six months respectively;
- Previous history of surgery on knees, ankles and hips in the last 2 years;
- Neurological disease;
- Inflammatory arthritis (eg. rheumatoid arthritis);
- Asymptomatic OA of one or both knees.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidade Federal de Sao Carloslead
- University of Sao Paulocollaborator
Study Sites (1)
Glauko Dantas
São Carlos, São Paulo, Brazil
Related Publications (2)
Dantas G, Sacco ICN, Dos Santos AF, Watari R, Matias AB, Serrao PRMS, Pott-Junior H, Salvini TF. Effects of a foot-ankle strengthening programme on clinical aspects and gait biomechanics in people with knee osteoarthritis: protocol for a randomised controlled trial. BMJ Open. 2020 Sep 25;10(9):e039279. doi: 10.1136/bmjopen-2020-039279.
PMID: 32978204RESULTDantas GAF, Sacco ICN, Ferrari AV, Matias AB, Watari R, Oliveira LVM, Marcon TR, Fatore JA, Pott-Junior H, Salvini TF. Effects of a foot-ankle muscle strengthening program on pain and function in individuals with knee osteoarthritis: a randomized controlled trial. Braz J Phys Ther. 2023 Jul-Aug;27(4):100531. doi: 10.1016/j.bjpt.2023.100531. Epub 2023 Aug 11.
PMID: 37603935RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator (MSc)
Study Record Dates
First Submitted
October 31, 2019
First Posted
November 6, 2019
Study Start
January 27, 2020
Primary Completion
March 1, 2020
Study Completion
August 4, 2023
Last Updated
April 2, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Participant data that underlie the results reported in this paper will be shared after blinding (text, tables, figures, appendices), immediately following publication.
- Access Criteria
- Requests for data or any form of analysis should be directed to glauko.ft.andre@hotmail.com or tania@ufscar.br. Requesters will be asked to sign a data access agreement.
All data collected during the trial will be compiled electronically. Data integrity and validity will be verified at the time of data entry (edit checks). The project manager and research assistant will regularly monitor the study datasets and make recommendations regarding necessary protocol modifications or termination of all or part of the study. Participant data that underlie the results reported in this paper will be shared after blinding (text, tables, figures, appendices), immediately following publication. In addition, the study protocol and clinical trial report (both with the planned statistical analysis) will be made available by the researchers who proposed the methodology. Requests for data or any form of analysis should be directed to glauko.ft.andre@hotmail.com or tania@ufscar.br. Requesters will be asked to sign a data access agreement.